Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by scarlet1967


T.TH

RE:RE:RE:RE:Wow

Again black and white assumptions, firstly in vivo/vitro results showed the...

February 18, 2022

T.TH

RE:Cognitive impairment among PLWH

https://clinicaltrials.gov/ct2/show/NCT02572323

February 18, 2022

T.TH

Cognitive impairment among PLWH

Cognitive Impairment - Capsule Summary Slidesets - Clinical Impact of New HIV...

February 18, 2022

T.TH

RE:New positions

One of them was duplicated, the point is we need new investors!

February 18, 2022

T.TH

New positions

These are all new positions as per the filings in the last week not large...

February 18, 2022

T.TH

RE:RE:RE:Worldwide

It is quite amazing what this drug can do with so many different indications....

February 17, 2022

T.TH

Trogarzo’s pricing

  Trogarzo’s price in Italy versus US absent any discounts!  ...

February 17, 2022

T.TH

RE:Worldwide

[0062] In view of their GHRHr agonist activity and GH-releasing properties...

February 17, 2022

T.TH

Worldwide

Looking at indications mentioned in the pattern they won't stop with...

February 17, 2022

T.TH

The role of Tesamorelin in liver fibrosis

  I don’t have access to the article which was published yesterday...

February 17, 2022

T.TH

RE:RE:RE:NASH management in PLWH

“Significant fibrosis” at 22% so we can rule out F1 patients which won’t need...

February 16, 2022

T.TH

NASH management in PLWH

If you jump to 5th minute the speaker makes a reference to Tesamorelin...

February 16, 2022

T.TH

RE:RE:RE:RE:RE:RE:Trog IV push data

Well as per yourself they did say the oncology takes longer but that is not...

February 16, 2022

T.TH

RE:RE:RE:RE:Trog IV push data

Well they had something to announce to some cherry picked investors in...

February 16, 2022

T.TH

RE:RE:RE:RE:RE:Trog IV push data

The issue is and has been they make no efforts to reach out to broader...

February 16, 2022

T.TH

Another ADC deal not Chinese this time

https://www.businesswire.com/news/home/20220215005481/en/ImmunoGen-Announces...

February 16, 2022

T.TH

RE:RE:PR - taking contract sales force inhouse

There are still focusing on “face to face” sales when the direction of most...

February 15, 2022

T.TH

RE:RE:PR - taking contract sales force inhouse

So far they contracted the sale force the advantages are less hands on and...

February 15, 2022

T.TH

RE:RE:RE:KOL on Ovarian treatments -for JUNIPER and some RECIST data

All the best to your wife yourself and the family. juniper88 wrote: I did a...

February 14, 2022

T.TH

RE:RE:siRNA powerful tool

https://academic.oup.com/narcancer/article/3/3/zcab030/6324600?login=false ...

February 14, 2022